CD79A and type 1 diabetes mellitus: As shown in Figure 3C, cluster 2 was significantly enriched in the upper pathways of graft-versus-host disease, systemic lupus erythematosus, allograft rejection, type I diabetes mellitus and intestinal immune network for IgA production.